An ‘eggs-traordinary’ career at Randox Teoranta for the first of the #Dungloe2020

Home - Business News - Page 26

An ‘eggs-traordinary’ career at Randox Teoranta for the first of the #Dungloe2020

As Easter arrives, global biotech firm Randox, is celebrating the success of its first recruitment drive, as part of its planned expansion under the #Dungloe2020 programme.

In October 2014, the company laid out its vision for Randox Teoranta, a leading life science and engineering centre, which includes a major investment of €25m in the site. This significant investment will see employment figures at Randox Teoranta rise to 540 by 2020.

Recruitment began in earnest in the New Year and for the last few weeks, the first of the #Dungloe2020 life scientists, engineers and software specialists have been getting to grips with their new roles at the frontline of improving healthcare; pioneering research and building technology to make a real difference in the diagnosis and treatment of conditions such as Alzheimer’s and diseases of the kidneys and liver.

One of the new recruits, Dr Lisa Staunton, a PhD in Protein Biochemistry, has been with Randox for two months:

“I’m passionate about what Randox is doing and pleased that I am using my experience to bring scientific breakthroughs in health care directly to the patient. I’m originally from Ballyshannon and was working at the Conway Institute at UCD, but now I can be at the cutting edge of research at home!

“Randox has a progressive way of making the most of your skills, I’m learning new skills from the team and they are learning from me, it is about how we can best fit each other to achieve our goals and not a lot of big companies have that flexibility. It is brilliant being able to put in a good, productive day in at the laboratory and then go for a run on Rossnowlagh beach.”

23 year old Mechanical Design Engineer, Darren McGeever is also among the first of the #Dungloe2020. Darren graduated in 2014, with an Honours in Mechanical Engineering from Letterkenny Institute of Technology and was concerned that he might have to emigrate:

“I’m heavily involved in the local GAA and Soccer teams and was worried that I would be joining a long list of former players who have had to emigrate for jobs; so I applied as soon as I heard about #Dungloe2020. It is just fantastic I could get a job like this right on my doorstep.

“I learn something new every day, the technology being developed here is truly ground-breaking and it is great to be part of that, so early on in my career. As well as studying at Letterkenny I.T., I also studied at Galway I.T., back then I used to go home to a cold house – now when I finish work I go to a warm house and my mum’s dinners!”

Dr Peter FitzGerald, Randox MD said harnessing the skills of the community is the key to success of the #Dungloe2020 campaign:

“The interest we’ve had to date is wonderful – we are attracting high calibre life scientists, engineers and software developers from within Donegal, the rest of Ireland and abroad. I’d like to congratulate and indeed welcome the first of our #Dungloe2020 staff, who will each play an important role as we strive to improve health across the globe.”

Steve Ó Cualáin, CEO at Údarás na Gaeltachta, is supporting the #Dungloe2020 recruitment drive:

“Údarás na Gaeltachta, are very pleased with the success of the first wave of recruitment for #Dungloe2020. We would like to support Randox Teoranta in their continued recruitment drive over the Easter period and we wish the company continued success with the campaign. We are confident that Randox will achieve its ambitious recruitment targets.”

For more information on the #Dungloe2020 positions available please visit randox.com or email recruitment@randoxteoranta.com


Colaboración en asistencia sanitaria destacada en la visita del Ministro de Salud irlandés a México

Una colaboración entre un laboratorio clínico pionero de México, Biomédica de Referencia y la empresa irlandesa de biotecnología, Randox, será el aspecto notable de la visita del Ministro de Salud irlandés al país.

El Ministro Leo Varadkar quien está en México para una serie de compromisos políticos y de negocios y para celebrar 40 años de relaciones diplomáticas entre México e Irlanda, hoy (18 de marzo 2015) hará una visita al laboratorio de vanguardia de Biomédica de Referencia en la zona de Lomas de Chapultepec en la ciudad de México. Esta empresa que ofrece excelencia en laboratorio clínico y diagnostico por imagen ha ganado varios honores internacionales y nacionales, incluso el Premio Nacional de Calidad 2014.

El Ministro Varadkar y la Embajadora de Irlanda para México, Sonja Hyland, observerán el uso de los productos de Randox en el laboratorio y encontrarán representantes del equipo dedicado para Latinoamérica de Randox. Hablarán también con los médicos y científicos pioneros de Biomédica de Referencia, que utilizan los productos de control de calidad de Randox para asegurar la exactitud y precisión en sus análisis de pacientes, lo que ha contribuido al estatus premiado del laboratorio.

Dando el bienvenido a la visita del Ministro de Salud, Clara Corona de Lau, Director Ejecutivo de Biomédica de Referencia dijo: “Para Biomédica de Referencia el contar con los productos de Randox desde el 2010, ha sido una herramienta invaluable en el aseguramiento de la calidad de los resultados. Los productos de Randox nos permiten tener procesos más eficientes al controlar todos nuestros sistemas en un solo programa, además que, el contar con matrices conmutables hace que la evaluación de los materiales de control refleje el desempeño analítico de manera similar al observado con las muestras de los pacientes; de igual manera, el tener resultados en “tiempo real” nos ha ayudado a tomar decisiones correctas en cuanto a nuestros sistemas analíticos, ayudándonos a fortalecer nuestros valores organizacionales de mejora continua e innovación. Estamos convencidos que en Randox Tenemos un aliado que en estos 5 años ha contribuido fuertemente al logro de nuestro reto de excelencia en la operación y en el posicionamiento de nuestra marca.”

Randox, un líder a nivel mundial en la industria de diagnóstico in vitro, exporta sus pruebas y tecnología innovadoras a hospitales, clínicos y laboratorios de investigación por todo México desde hace casi 20 años. Dominic Hasson, Gerente para Latinoamérica de Randox dijo que el éxito del equipo es debido a la fortaleza de los productos de Randox y al desarrollar buenas relaciones:

“Randox exporta a 20 países en Latinoamérica, y muchos de éstos están fortaleciendo sus sistemas de asistencia de salud. Debido a esto, estamos viendo una mayor demanda cada año de nuestros productos diagnósticos de alta calidad; y México no es una excepción. Randox ha invertido en personal hispanohablante para apoyar a este mercado, suministrando equipos dedicados para esta región que trabaja en desarrollar y mantener relaciones con clientes; esto es esencial para hacer crecer la presencia de Randox en Latinoamérica.”

El Ministro de Salud Leo Varadkar dijo: “La relación fuerte entre Biomédica de Referencia y Randox es un ejemplo claro del valor de la colaboración entre empresas mexicanas e irlandesas en el sector de salud. Como Ministro de Salud, estoy muy orgulloso del hecho de que productos de control de calidad desarrollados y fabricados por una empresa irlandesa han contribuido al otorgamiento del Premio Nacional de Calidad 2014 a Biomédica de Referencia.”

La Embajadora de Irlanda para México, Sonja Hyland, dijo: “México es el socio comercial más grande de Irlanda en Latinoamérica y el sector de productos médicos y farmacéuticos es una parte importante y creciente de esta relación, representando casi $400 millones de negocios entre México e Irlanda. La visita del Ministro Varadkar a México nos da la oportunidad de desarrollar y fortalecer aún más esta relación.”


Irish biotech firm Randox announces export success to Latin America as 2014 sales exceed €7 million

Irish biotechnology company Randox Laboratories is highlighting the impact of its export strategy to Latin America, as sales of the firm’s products into the region in 2014 exceed €7 million. The announcement comes as Health Minister, Leo Varadkar visits Mexico’s leading clinical laboratory to see Randox products in use.

Randox, a global market leader within the in vitro diagnostics industry, has been exporting its innovative tests and technology to hospitals, clinics and R&D labs across Mexico for almost 20 years. One of the company’s key customers in the country is principal clinical laboratory, Biomédica de Referencia, based in Mexico City, winner of the prestigious 2014 Mexican National Quality Award.

Today (18th March 2015), the Health Minister and Irish Ambassador, will tour the state-of-the-art facility and will meet representatives from Randox’s dedicated Latin America team. They will also speak to the pioneering medics and scientists at Biomédica de Referencia, who use Randox Quality Control products to ensure accuracy in patient testing.

Welcoming the Health Minister’s visit, Dominic Hasson, Randox’s Latin America Manager said the team’s success is due to the strength of Randox products and to developing good relations:

“Randox exports to 20 countries in Latin America, many of which are strengthening their healthcare systems and as a result we are seeing increased demand for our high quality diagnostic products, year-on-year; Mexico is no exception. Randox has invested in Spanish speaking staff to assist with this market, providing teams dedicated to the region, who work to develop and maintain relationships with customers; this is vital to growing the Randox footprint in Latin America.”

Health Minister Leo Varadkar said: “The strong relationship between Biomédica de Referencia and Randox is a clear example of the value of collaboration between Mexican and Irish companies in the healthcare sector. As Minister for Health, I am very proud that quality control products developed and manufactured by an Irish company have contributed to Biomédica de Referencia receiving the 2014 Mexican National Quality Control Award.”

Irish Ambassador to Mexico, Sonja Hyland said: “Mexico is Ireland’s largest trading partner in Latin America and the pharmaceutical, medical devices and medical products sector is an important and growing part of that relationship, accounting for nearly $400 million of business between Mexico and Ireland. Minister Varadkar’s visit to Mexico gives us an opportunity to further develop and strengthen that relationship.”

Clara Corona de Lau of Biomédica de Referencia said: “For Biomédica de Referencia, the use of Randox products since 2010 has been an invaluable tool in assuring the quality of our results. Randox products allow us to have more efficient processes to control all our systems with one programme, and in addition to this, having commutable matrixes means that evaluation of the control materials reflects our analytical performance in a similar way to that seen with patient samples. Also, having “real time” results has helped us to take correct decisions in regards to our analytical systems, helping us to strengthen our organizational values of continuous improvement and innovation. We are convinced that with Randox we have an ally, which in these last 5 years has contributed strongly to the achievement of our goals of operational excellence and positioning of our brand.”


The Only Way is Apex

Global biotechnology firm Randox Laboratories, in partnership with Queen’s University, Belfast, is offering STEM and Business Management students a chance to reach the top, with a new industrial training programme.

Today (Wed 4th March), the award winning clinical diagnostics company, kick starts ‘Randox Apex’, a scheme which will create up to 40 opportunities each year, for full time undergraduate students at Queen’s.

The industrial training will see selected students awarded paid, full-time summer work experience throughout their degree, a paid placement for their Professional Experience Year and after graduation, they will be offered jobs with Randox, subject to gaining a 2:1 or above.

First year students from the School of Management; Electronics, Electrical Engineering & Computer Science (EEECS); Mathematics & Physics; Mechanical Engineering, Chemistry and the School of Biological Sciences, will be eligible to apply to Randox Apex.

Randox Apex students will be placed in divisions spanning the breadth of the company and in various locations; from Randox’s headquarters in Crumlin; to its high-spec forensics laboratory in Manchester; to its flagship diagnostics clinic in London and the new Randox Science Park in Antrim, opportunities at Randox Teoranta in Donegal and at Randox’s facility in the Greater Washington area, USA, could also be available. The aim is to develop skills across the board as, Randox Human Resources Manager, Linda Magee explains:

“Students accepted onto Randox Apex will be working with and learning from the best, across a range of departments within their discipline. They might be assisting our ground-breaking research into tests for cancer, kidney disease and Alzheimer’s, they could be working on engineering cutting edge diagnostic technology, they’ll have the opportunity to experience a busy forensics laboratory, or they could be joining our business development teams as they expand the Randox footprint across the globe.

“We are delighted to be partnering Queen’s in this new programme and look forward to nurturing new generations of pioneering scientists, engineers and business leaders.”

Speaking at the launch of Randox Apex at Queen’s Student Guidance Hub, Professor David Jones, Pro-Vice-Chancellor for Education, said: “At Queen’s we are committed to providing an exceptional student experience and high quality education that leads to excellent career opportunities for our graduates.

“This exciting training scheme, run in partnership with Randox Laboratories, will offer our STEM and Business Management students the opportunity to gain invaluable experience and skills, test themselves in the workplace, and prove they have the attributes needed to gain employment at one of Northern Ireland’s most pioneering companies.”


Randox Puts Health In The Frontline As Winner Of Prestigious European Business Awards

Leading clinical diagnostics company Randox is delighted to have been selected as a ‘Ruban D’Honneur’ winner for imports/exports in the prestigious European Business Awards 2014/15.

Having gone head to head with some of the biggest business names in Europe, this esteemed award recognises Randox as one of the most dynamic and exciting businesses in Europe, lauding Randox’s success in imports/exports across the Globe.

From its headquarters in Crumlin Co. Antrim, Randox has grown into an international success story, at the frontline of improving health in conditions such as stroke, dementia, diabetes, heart disease, STI’s and respiratory infections through earlier and more accurate diagnosis.

Every year a staggering 350 million people – 5% of the world’ population – are diagnosed with Randox products. Randox supplies 10% of the world’s cholesterol tests, and 8% of all clinical chemistry tests undertaken globally. In being shortlisted as one of ten European winners, the importance of Randox successful global export strategy has been recognised.

Randox are striding forward: driven by innovation and a commitment to saving lives, Randox currently has more clinical diagnostic tests in development than any other company in the world. Randox recently announced ambitious plans to develop Randox Science Park in Antrim – a centre for excellence in clinical research & development, engineering and transformative health.

Dr Peter FitzGerald, Managing Director of Randox said:

“We are delighted to have won this prestigious award, in recognition of our key objective – to save lives globally. Our success is built on world-class, innovative products which enable earlier, more accurate diagnosis. Randox products improve the quality of life and enhance the efficiency of healthcare, saving lives right across the world. This award is clear recognition of the difference Randox can make to health globally.”

To watch Randox’s entry-winning video visit https://www.youtube.com/watch?v=7RmK_OkAMFc
For more information on the European Business Awards, visit www.businessawardseurope.com.


NI company Randox bucks the trend in providing forensic services to GB police forces

Leading forensic toxicology company, Randox, are riding high despite a recent National Audit Office report which raised concerns about a reducing marketplace for private forensic services.

The Co. Antrim-based company are bucking the trend and growing market-share, and in 2014 provided forensic services to all 43 police forces across England and Wales.

Recently the NAO raised concerns that a shrinking private forensic marketplace will result in reduced capacity, and detrimentally impact the judicial process. 

At present UK police forces can either conduct forensic toxicology testing in-house, where such laboratory facilities exist, or outsource the work to one of ten fully-accredited service providers – including Randox – through the National Forensic Framework procurement process.

Under the Framework, all private forensic service providers must be fully accredited, which is a costly process but ensures that rigorous practices are upheld. The NAO highlights that the Forensic Regulator does not have powers to force police labs to comply with accreditation standards. 

As police budgets are cut and more forensics are brought in-house, expenditure on private sector forensic services have declined significantly, to around £60m a year. 

NAO highlights a growing concern in the industry that if forensic services continue to move in-house this will force some private operators to pull out of the market. 

Gary McCutcheon, Manager of Randox Testing Services said: 

“Randox is extremely proud to be one of only 10 forensic providers on the National Forensic Framework: all 43 police services in England and Wales have used Randox’s forensic toxicology services. The fact we are now an established provider, meeting and exceeding standards, means we are a major player and puts us in a strong position going forward.

“Having achieved considerable success in GB police forces we are in a strong position, when circumstances allow, to provide the same first class services and considerable cost savings to forensic toxicology users in Northern Ireland.”


Randox Strengthens Regional Commitment with Expansion Plans in County Antrim

  • £161m investment including £29m capital project and creation of 540 jobs
  •  Next generation medical diagnostics manufacturing facility
  • World leading R&D into conditions such as cancer, stroke, heart disease, neurodegenerative disorders, sepsis, STIs, aspirin resistance and respiratory infections
  • Randox Science Park to complement Randox Teoranta’s #Dungloe2020 expansion

“This investment and expansion in County Antrim, combined with our plans for Randox Teoranta in Donegal, provides us with an extraordinary regional footprint, which will be the foundation of our global development and which will fuel our endeavours to improve health worldwide…”

Global medical diagnostics company Randox, has unveiled its plans for a futuristic manufacturing and R&D facility in County Antrim. The £161 million project, which includes a £29 million capital investment for the redevelopment of the site, will lead to the creation of 540 high value job opportunities, over the next four years.

Randox which leads in the research, development and manufacture of pioneering medical tests and cutting edge diagnostic equipment, recently revealed its plans to upgrade Randox Teoranta, in Donegal with a €25m investment, which would also see employment at the Dungloe site increase from 66 to 540 by 2020. 

The award-winning biotechnology firm, with headquarters in Crumlin, County Antrim, recently purchased a 47 acre site in Antrim, which will be redeveloped to house a new centre of manufacturing and R&D, named Randox Science Park. 

Randox Science Park, will complement Randox manufacturing operations in County Donegal, Manchester, India and the USA. Randox has a range of 2000 products, including advanced diagnostic tests, quality control sera, analysers and the company’s revolutionary BioChip Array Technology; the vast majority will be produced between Co Donegal and Co Antrim.

This considerable investment will accelerate the development of new products into a wide range of clinical needs, such as various cancer, stroke, heart disease and neurodegenerative disorders, through more efficient, high specification manufacturing and the provision of state-of-the-art R&D laboratories. 

The site will also feature a Transformative Healthcare Centre from the Randox Health division; giving the public direct access to Randox’s ground-breaking diagnostic tests, as well as offering private GP appointments and specialist clinics, run by some of the North of Ireland’s chief medical consultants.

At a launch event today, Randox showcased its plans for Randox Science Park. Guests including Northern Ireland’s First Minister, Peter Robinson, Deputy First Minister, Martin McGuinness and Enterprise Minister, Arlene Foster, were briefed on the company’s impact on global health and vision for the future.

Speaking at the event, Randox Managing Director, Dr Peter FitzGerald said: 

“The creation of Randox Science Park is fundamental to Randox meeting the health challenges facing populations across the world. We are an innovation led company, focusing more than 30 years of skills and experience on delivering accurate, rapid and quality diagnostics across a range of clinical disciplines; from stroke and heart disease, to cancer, neurodegenerative disorders, respiratory infections and so on. We must continue innovating, through our people, through our knowledge and through our technology; Randox Science Park gives us the platform we need to do this.

“This investment and expansion in County Antrim, combined with our plans for Randox Teoranta in Donegal, provides us with an extraordinary regional footprint, which will be the foundation of our global development and which will fuel our determination to improve health worldwide. It is about the future of diagnostic medicine; we are beginning 2015 as we mean to continue.”

Meanwhile the first recruitment drive for the #Dungloe2020 expansion of Randox Teoranta, which has backing from Údarás na Gaeltachta continues. The company is keen to hear from those in life sciences, medical device engineering and software; with a particular focus on software developers and testers, embedded software engineers, those with backgrounds in mechanical design as well as electronic & electrical engineers. For more information on the world-class career opportunities available at Randox Teoranta please email recruitment@randoxteoranta.com


Randox puts British Biotechnology on World Map with New Randox Science Park

  •  £161m investment including £29m capital project and creation of 540 jobs
  • Next generation medical diagnostics manufacturing facility
  • World leading R&D into conditions such as cancer, stroke, heart disease, neurodegenerative disorders, STIs, aspirin resistance, sepsis and respiratory infections

“This investment and expansion reinforces our dedication to improving health worldwide…”

Global medical diagnostics company Randox, has unveiled its plans for a futuristic manufacturing and R&D facility in the UK. The £161 million project, which includes a £29 million capital investment for the redevelopment of the site, will accelerate the development of new products into a wide range of clinical needs, such as various cancers, stroke, heart disease and neurodegenerative disorders, through more efficient, high specification manufacturing and the provision of state-of-the-art R&D laboratories. 

Randox leads in the research, development and manufacture of pioneering medical tests and cutting edge diagnostic equipment, with customers in clinical, toxicology, veterinary and food safety markets in more than 145 countries.

The award-winning biotechnology firm, with headquarters in Crumlin, County Antrim, recently purchased the former British Army base at Massereene, in Antrim town, which will be redeveloped to house the new centre of manufacturing and R&D, now renamed, Randox Science Park. 

Randox Science Park will become the company’s prime manufacturing site, complementary to its manufacturing operations in Manchester, Republic of Ireland, India and the USA. Randox has a range of more than 2000 products, including advanced diagnostic tests, quality control sera, analysers and the company’s revolutionary BioChip Array Technology; many of which will be produced at this next generation facility.

This considerable investment will also lead to the creation of 540 high value job opportunities, over the next four years.

In addition, the site will feature a Transformative Healthcare Centre from the Randox Health division; giving the public direct access to Randox’s ground-breaking tests, as well as offering private GP appointments and specialist clinics, run by some of the UK’s chief medical consultants.

At a launch event today, Randox showcased its plans for Randox Science Park. Guests including Northern Ireland’s First Minister, Peter Robinson, Deputy First Minister, Martin McGuinness and Enterprise Minister, Arlene Foster, were briefed on the company’s impact on global health and vision for the future.

Speaking at the event, Randox Managing Director, Dr Peter FitzGerald said: 

“The creation of Randox Science Park is fundamental to Randox meeting the health challenges facing populations across the world. We are an innovation led company, focusing more than 30 years of skills and experience on delivering accurate, rapid and quality diagnostics across a range of clinical disciplines; from stroke and heart disease, to cancer, neurodegenerative disorders, respiratory infections and so on. We must continue innovating, through our people, through our knowledge and through our technology; Randox Science Park gives us the platform we need to do this.

“Randox innovation underpins our achievements, allows us to diversify, allows us to target fresh markets and fuels our exports and Randox Science Park will be at its core. This investment and expansion reinforces our dedication to improving health worldwide and our commitment to the UK economy. It is about the future of diagnostic medicine, we are beginning 2015 as we mean to continue.”

The expansion includes the creation of manufacturing, scientific and engineering opportunities on a major scale, as well as business support posts; the investment will also grow Randox’s sales and marketing capabilities. In addition, the 540 new jobs, with an average salary of £30k per year will generate £16.2 million in annual salaries, representing a significant boost to the UK economy. 

The company said it was already engaging with universities across the UK, to access high calibre graduates for the world class opportunities at Randox Science Park.

Regional development agency, Invest Northern Ireland is supporting the £29m Randox capital redevelopment of the site, with an investment of £4.7 million.


Vote Randox as UK National Champion in the European Business Awards 2015

Leading clinical diagnostics firm Randox Laboratories goes head to head with some of the biggest brands in the UK, as it competes for the title of ‘National UK Champion’ in the European Business Awards 2015.

Randox, having already faced stiff competition from across the UK to be shortlisted as a National Champion, will now face the public vote and are asking you to put health at the frontline by supporting them.

Randox will be judged by the public from a company video which gives a powerful and inspiring insight into the story of Randox. 

From its headquarters in Crumlin Co Antrim, Randox has grown into an international success story, at the frontline of improving health in conditions such as stroke, dementia, diabetes, heart disease, STI’s and respiratory infections through earlier and more accurate diagnosis. 

Every year a staggering 350 million people – 5% of the world’s population – are diagnosed with Randox products. Randox supplies 10% of the world’s cholesterol tests, and 8% of all clinical chemistry tests undertaken globally: the chances are if you’ve ever had blood taken by a doctor it’s been assessed using a Randox product. 

Randox aren’t standing still: driven by innovation and a commitment to saving lives, Randox currently has more clinical diagnostic tests in development than any other company in the world.

To watch Randox’s video and cast your vote go to www.businessawardseurope.com (or click here.). 

Why vote for Randox? Dr Peter Fitzgerald, Managing Director of Randox says: 

“Randox’s key driver is to save lives. Our raison d‘etre is to improve health not just here in Northern Ireland but right across the world. Our success is built on world-class, innovative products which enable earlier, more accurate diagnosis. In doing so we improve the quality of life, enhance the efficiency of healthcare and save lives, globally.”

Randox will compete against other UK shortlisted Champions for the public vote. The company with the most votes will be named the UK’s ‘National Public Champion’ on 3rd March 2015. From this, National Champions will have the opportunity to compete with winners from across Europe to earn the highly acclaimed title of ‘European Public Champion’ at a glittering Awards Gala event in May 2015.

For more information on the European Business Awards, please visit www.businessawardseurope.com or Randox atwww.randox.com.


Randox Teoranta ‘decks the halls’ as part of major recruitment drive

Global biotechnology firm Randox, is announcing that recruitment for the expansion of its facility in Dungloe is now underway.  In October the company laid out its vision for Randox Teoranta, its cutting-edge life science and engineering centre, which included a major investment of €25m in the site and a jobs boost of almost 500 posts to be filled by 2020.

The first wave of recruitment for #Dungloe2020 has just begun, with the initial focus on electrical, mechanical and software engineers as Dr Peter FitzGerald, Randox MD explains: 

“We are very pleased that the recruitment process is now open for the first of the #Dungloe2020 positions.  At the moment, we are keen to hear from those in life sciences, medical device engineering and software; with a particular focus on Software developers and testers, embedded software engineers, those with backgrounds in mechanical design as well as electronic & electrical engineers.  

Randox Teoranta is a next generation life-sciences and engineering research and manufacturing centre, the site of pioneering research into conditions impacting human health such as alzheimer’s and diseases of the kidneys and liver.  We hope to encourage scientists and engineers returning for Christmas, to consider returning for good to pursue world class careers at home.”

Stiofán Ó Cualáin, CEO, Údarás na Gaeltachta, says they are backing the campaign: 

“We are delighted to hear that Randox Teoranta is now commencing its recruitment campaign following the company’s recent announcement of its expansion plans at its facility in An Clochán Liath. Údarás na Gaeltachta, are pleased to be able support Randox Teo. in this recruitment drive. The people that will be employed in these new jobs will play an important role in the growth and continued development of Randox Teoranta. and we wish the company every success with their campaign.”

Randox Teoranta is holding a ‘drop-in’ morning, Wednesday 24th December during the hours of 0900-1200 for anyone interested in the career opportunities available.  Representatives from the company will be happy to discuss the #Dungloe2020 expansion and recruitment.

For more information on the #Dungloe2020 positions advertised please visit randox.com  or emailrecruitment@randoxteoranta.com


Request a meeting
×
Make an Enquiry - RX series
×
Make an Enquiry - Reagents
×
Kit Insert Request - Reagents
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Kit Insert Request - Reagents
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Make an Enquiry - Reagents
×
Make an Enquiry - Quality Control
×
Make an Enquiry - RIQAS
×
Make an Enquiry - RIQAS
×
Make an Enquiry - Quality Control
×
Make an Enquiry
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Make an Enquiry - Biochip
  • This field is for validation purposes and should be left unchanged.
×
Make an Enquiry - Molecular
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
  • This field is for validation purposes and should be left unchanged.
×
Make an Enquiry - Future Diagnostics
×
Make an Enquiry - RX series (Product)
×
Make an Enquiry - Quality Control
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Make an Enquiry - RIQAS
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Make an Enquiry - Reagents
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Por favor, introduzca sus datos para ver nuestro último seminario
×
Wyślij zapytanie
  • Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, które są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktów,akutalizacji obecnych, trendów rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje Polityki Prywatności.
×
Wyślij zapytanie
  • Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, które są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktów,akutalizacji obecnych, trendów rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje polityki prywatności.
×
Wyślij zapytanie
  • Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, które są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktów,akutalizacji obecnych, trendów rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje polityki prywatności.
×
Wyślij zapytanie
    Rejestracja na naszej liście mailowej jest szybka i łatwa. Nie chcemy wysyłać e-maili zawierających spam lub wiadomości, które są automatycznie przekierowywane do kosza. W zawiązku z czym firma Randox deklaruje, że będzie wysyłac tylko informacje na temat nowych produktów,akutalizacji obecnych, trendów rynkowych, wydarzeń branżowych itp. Firma Randox Laboraotries obiecuje, że Państwa dane nie będą nigdzie przekazane, a przechowywanie owych danych będzie się odbywało z zachowaniem największego bezpieczeństwa. Prosimy o przeczytani naszje polityki prywatności .
×
귀하의 문의 사항 제출
    Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
귀하의 문의 사항 제출
×
귀하의 문의 사항 제출
×
귀하의 문의 사항 제출
×
Downloads
×
Contact

<p>

    Randox Clinical Chemistry Products Join the Randox Laboratories Mailing List * I would like to receive emails with new product releases and updates from Randox Laboratories, market trends, and more. I do not want to receive email marketing from Randox. Signing up to our mailing list is quick and easy. We do not want to send you any spam or junk emails, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promises never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
</p>

×
Enquire Now - Coronavirus Testing
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details safe and secure. Read more in our Privacy Policy.
×